Rutgers and Stanford scientists develop novel way to inject healthy human nerve cells into the brain
Scientists at Rutgers and Stanford universities have created a new technology that could someday help treat Parkinson’s disease and other devastating brain-related conditions that affect millions of people.
“If you can transplant cells in a way that mimics how these cells are already configured in the brain, then you’re one step closer to getting the brain to communicate with the cells that you’re now transplanting,” said Moghe, research director for the School of Engineering/Health Sciences Partnerships at Rutgers. “In this work, we’ve done that by providing cues for neurons to rapidly network in 3-D.”
Neurons, or nerve cells, are critical for human health and functioning. Human brains have about 100 billion neurons, which serve as messengers that transmit signals from the body to the brain and vice versa.
Moghe said a 3-D scaffold, developed by the scientists, consists of tiny polymer fibers. Hundreds of neurons attach to the fibers and branch out, sending their signals. Scaffolds are about 100 micrometers wide – roughly the width of a human hair.
“We take a whole bunch of these islands and then we inject them into the brain of the mouse,” he said. “These neurons that are transplanted into the brain actually survived quite miraculously well. In fact, they survived so much better than the gold standard in the field.”
Indeed, the scaffold technology results in a 100-fold increase in cell survival over other methods, Moghe said.
And that may eventually help people suffering from Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, Alzheimer’s disease, spinal cord and traumatic brain injuries, and concussions, he said.
These diseases and conditions often arise from the loss of brain cells. Parkinson’s disease, for example, is caused by the loss of brain cells that produce dopamine, a key neurotransmitter. Brain cell loss can lead to trembling in the hands, arms, legs, jaw and face; rigidity, or stiffness of the limbs and trunk; slowness of movement; and impaired balance and coordination, according to the National Institutes of Health.
The next step would be to further improve the scaffold biomaterials, allowing scientists to increase the number of implanted neurons in the brain. “The more neurons we can transplant, the more therapeutic benefits you can bring to the disease,” Moghe said. “We want to try to stuff as many neurons as we can in as little space as we can.”
The idea is to “create a very dense circuitry of neurons that is not only highly functioning but also better controlled,” he said, adding that testing of mice with Parkinson’s disease is underway to see if they improve or recover from the illness.
Eventually, with continued progress, the researchers could perform studies in people. Moghe estimated that it would take 10 to 20 years to test the technology in humans.
Developing the scaffold technology and reprogramming the stem cells in the scaffolds was “very hard team work,” he said. “It took many years to get here, so there was a lot of sweat and toil.”
The Latest on: Stem cell bioengineering
via Google News
The Latest on: Stem cell bioengineering
- Engineering bunched Pt-Ni alloy nanocages for efficient oxygen reduction in practical fuel cellson November 14, 2019 at 12:00 pm
3 Innovation Research Center for Fuel Cells, The University of Electro-Communications ... PR China. 8 School of Chemical and Biomedical Engineering, Nanyang Technological University, 62 Nanyang Drive, ...
- Novel Fluorescence Lifetime Imaging Tool May Advance Cancer Careon November 14, 2019 at 5:12 am
This new approach reconstructs multiple lifetime images at the same time, providing a comprehensive view of multiple biological processes happening within the tissue and cells, said Pingkun Yan, PhD, ...
- Deep neural network could improve cancer careon November 13, 2019 at 11:46 am
Xavier Intes, a professor of biomedical engineering who led this research for Rensselaer Fluorescence lifetime imaging has long been a helpful way for scientists and engineers to see molecular-level ...
- ELeCt-ing a better candidate for chemo deliveryon November 13, 2019 at 11:03 am
who is a Core Faculty member at the Wyss Institute as well as the Hiller Professor of Bioengineering and Hansjörg Wyss Professor of Biologically Inspired Engineering at SEAS. Further studies will ...
- Study Identifies Individual Human Brain Memory Trace Cells that Recall Spatial Position of Objectson November 13, 2019 at 7:18 am
Studies headed by neuroengineers at Columbia University’s department of biomedical engineering have now found the first evidence that individual neurons in the human brain, known as “memory-trace ...
- MEng Molecular Bioengineering with a Year Abroadon November 13, 2019 at 2:05 am
By contrast, Molecular Bioengineering takes a bottom-up approach, first looking at cells and molecules, then building up from tissues and organs to the whole organism or human. Transfer between the ...
- Researchers battle "zombie cells," ward off age-related diseaseson November 12, 2019 at 8:33 pm
who works with senescent cells at the Mayo Clinic as a consultant in the Department of Physiology and Biomedical Engineering. Research on senescent cells in humans began earlier this year and is still ...
- Fluorescent carbon dots can effectively detect calcium levels in cellson November 12, 2019 at 8:44 am
In hospitals, doctors often advise patients to take calcium supplements. But does the calcium get into the cells that need it? Until recently, it's been hard to tell. But now, Prof. DONG Wenfei's ...
- Research Roundup: Heart muscle cells in space, genetic history of Rome, eating disorderson November 10, 2019 at 10:57 pm
The cells reverted back to their normal state when returning to Earth. “Working with the cells that launched to and returned from the International Space Station was an incredible opportunity,” said ...
- Blood Cancers: New Generation Stem Cell Transplant Decreases Complications for Patientson November 5, 2019 at 11:42 pm
the Université de Montréal is the sole proprietor of this molecule, which is covered by an exclusive international license granted to ExCellThera, a Montreal-based advanced clinical-stage ...
via Bing News